New diagnostic kits aim to revolutionize early screening of the disease, potentially allowing patients to receive ...

A trial looking into the potential of new and existing blood tests to diagnose people with dementia could "revolutionise" ...

May 16 (UPI) --The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in patients beginning to show cognitive decline. Fujirebio ...

More than 580,000 bottles of prazosin hydrochloride capsules have been recalled after tests found potential cancer-causing ...

The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, making the test the first to get signoff to aid in the early detection of the ...

The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not. By Pam Belluck A blood test that can help diagnose Alzheimer’s disease has received ...

WASHINGTON — U.S. health officials on Friday endorsed the first blood test that can help diagnose Alzheimer’s and identify patients who may benefit from drugs that can modestly slow the ...

A blood sample analysis can detect markers of this disease at early stages, providing a cheaper and less invasive option for diagnosis. In clinical trials, the Lumipulse blood test was highly accurate ...

Cardiologists highlight Lipoprotein(a), or Lp(a), a blood component that silently increases heart attack and stroke risk. Even healthy individuals with normal cholesterol can be at risk. Lp(a) is ...

(THE CONVERSATION) A generic blood pressure drug called prazosin, made by Teva Pharmaceuticals, is being recalled by the Food and Drug Administration because it contains elevated levels of ...

Teva Pharmaceuticals’ prazosin is just one of many generic versions – but it’s the only one that is contaminated ...